Failure of Heparin to Prevent Progression in Progressing Ischemic Infarction
Stroke 19:10-14, Haley,E.C.,et al, 1988
Medical Treatment of Transient Ischemic Attacks:Does it Influence Mortality
Stroke 19:397-400, Ramirez-Lassepas,M.&Cipolle,R.J., 1988
Vertebral Artery Dissection
Neurol 38:987-989, Hart,R.G., 1988
Anticoagulant Therapy in Cerebrovascular Disease:Review and Meta-Analysis
Stroke 19:1043-1048, Jonas,S., 1988
Heparin Anticoagulation in Acute Brain Ischemia
Stroke 19:403-406, Miller,V.T.&Hart,R.G., 1988
Atrial Fibrillation and Stroke:New Ideas, Persisting Dilemmas
Stroke 19:937-941, Halperin,J.L.&Hart,R.G., 1988
Complications of Long-Term Anticoagulation
Ann Neurol 23:570-574, Petty,G.W.,et al, 1988
Cooperative Study on the Value of Long Term Anticoagulation in Pts with Stroke & Non-Rheumatic Atrial Fibrillation
BMJ 296:1435-1438, Lodder,J.,et al, 1988
Intraluminal Thrombus in the Cerebral Circulation, Implications for Surgical Management
Stroke 19:681-687, Buchan,A.,et al, 1988
The Role of Anticoagulation in Cavernous Sinus Thrombosis
Neurol 38:517-522, Levine,S.R.,et al, 1988
Macular Hemorrhage in the Aging Eye:The Effects of Anticoagulants
NEJM 318:1126-1127, Kingham,J.D.,et al, 1988
Reye's Syndrome and Aspirin, Evidence for a Dose-Response Effect
JAMA 260:657-661, Pinsky,P.F.,et al, 1988
Extracranial Vertebral Artery Dissections:A Review of 13 Cases
Stroke 18:1037-1047, Mas,J.,et al, 1987
Public Health Service Study of Reye's Syndrome & Medications, Report of the Main Study
JAMA 257:1905-1911, 19411987., Hurwitz,E.S.,et al, 1987
Basilar Artery Stenosis:Middle & Distal Segments
Neurol 37:1742-1746, Pessin,M.S.,et al, 1987
Single Studies & Overview Analyses:Is Aspirin of Value in Cerebral Ischemia
Stroke 18:541-544, Gent,M., 1987
Brain Cardioembolism, Issues in Diagnosis & Management
Postgrad Med 82:48-57, Anderson,D.C., 1987
A Multicenter Study of Anticoagulation Parameters When Using Heparin & Warfarin
Arch Neurol 44:1229-1231, Alberts,M.J.,et al, 1987
The Fluid-Blood Level in Intracranial Haematoma Due to Anticoagulant Medication
JNNP 50:1076, Weisberg,L.A., 1987
Cerebral Infarction from Non-Bacterial Thrombotic Endocarditis, Clin & Path Study Including the Effects of Anticoag
Am J Med 83:746-756, Rogers,L.R.,et al, 1987
Nontraumatic Spinal Epidural & Subdural Hematomas
Neurol 37:1351-1356, Mattle,H.,et al, 1987
Clinical Valproate Toxicity Induced by Acetylsalicylic Acid
Neurol 37:1392-1394, Goulden,K.J.,et al, 1987
Current Medical & Surgical Therapy for Cerebrovascular Disease
NEJM 317:1505-1516, Grotta,J.C., 1987
The European Stroke Prevention Study (ESPS) Principal End-Points
The ESPS Group, Lancet 2:1351-13541987., , 1987
Cerebral Ischemia with Mitral Valve Prolapse
Am Heart J 113:1308-1315, Wolf,P.A.,et al, 1987
Interhemispheric Subdural Hematoma
Can J Neurol Sci 14:172-174, Russell,N.A.,et al, 1987
High-Dose Acetylsalicylic Acid after Cerebral Infarction
A Swedish Cooperative Study, Stroke 18:325-3341987., , 1987
Cardioembolic Stroke
Early Anticoagulation, & Brain Hemorrhage, Cerebral Embolism Study Group, Arch Int Med 147:636-640., , 1987
Intravenous Heparin for the Prevention of Stroke Progression in Acute Partial Stable Stroke:A Random Controll Trial
Ann Int Med 105:825-828, Duke,R.J.,et al, 1986
Embolic Complications in Paroxysmal Atrial Fibrillation
Stroke 17:622-626, Petersen,P.&Godtfredsen,J., 1986
Therapeutic Range for the Control of Oral Anticoagulant Therapy
Arch Neurol 43:1162-1164, Hirsh,J.&Levine,M., 1986
No Effect of Acetylsalicylic Acid on B-Thromboglobulin & Platelet Factor 4 Plasma Levels in Patients with TIA's
Stroke 17:1153-1155, Carrieri,P.,et al, 1986
The Clinical Spectrum of Hemorrhagic Infarction
Stroke 17:630-637, Ott,B.R.,et al, 1986
Hemorrhagic Infarcts
Stroke 17:586-589, Hart,R.G.&Easton,D., 1986
Reye's Syndrome & Aspirin
BMJ 292:1543-1544, 15901986., Tarlow,M., 1986
Cardiogenic Brain Embolism
Cerebral Embolism Task Force, Arch Neurol 43:71-841986., , 1986
The Secondary Prevention of Stroke in Patients with Atrial Fibrillation
Arch Neurol 43:66-68, 701986., Starkey,I.&Warlow,C., 1986
The Secondary Prevention of Stroke in Patients with Atrial Fibrillation
Arch Neurol 43:68-70, Sherman,D.G.,et al, 1986
Treatment of Acute Ischemic Stroke, Open Trial with Continuous Intravenous Heparinization
Arch Neurol 43:386-390, Ramirez-Lassepas,M.,et al, 1986
Hemorrhagic Complications of Long-Term Anticoagulant Therapy for Ischemic Cerebral Vascular Disease
Stroke 17:111-116, Levine,J.&Hirsh,J., 1986
Aspirin:What Dose? Editorial
Lancet 1:592-593, , 1986
Dissections
Stroke 16:925-927, Hart,R.G.&Easton,J.D., 1985
Vertebrobasilar Insufficiency, A Review
Arch Neurol 42:803-808, Ausman,J.I.,et al, 1985
Persantine Aspirin Trial in Cerebral Ischemia Part II:Endpoint Results
The American-Canadian Co-Operative Study Group, Stroke 16:406-4151985., , 1985
Usefulness of Heparin in Initial Management of Patients with Recent Transient Ischemic Attacks
Arch Neurol 42:960-962, Putman,S.F.&Adams,H.P., 1985
Does Platelet Antiaggregant Therapy Lessen the Severity of Stroke
Neurol 35:632-636, Grotta,J.C.,et al, 1985
Naproxen in Prophylaxis of Migraine
Arch Neurol 42:582-584, Ziegler,D.K.,et al, 1985
Stroke, The Use & Overuse of Heparin in Therapeutic Trials
Arch Neurol 42:315-317, Sage,J.I., 1985
Anticoagulant-Related Intracerebral Hemorrhage
Neurol 35:943-948, Kase,C.S.,et al, 1985
Public Health Service Study on Reye's Syndrome & Medications, Report of the Pilot Phase
NEJM 313:849-857, Hurwitz,E.S.,et al, 1985